Biocept Expands Its Blood Test For Breast Cancer - And Lung Cancers
July 01, 2015 at 14:25 PM EDT
Shares of Biocept soared as much as 46% after the company reported new cancer indications for its blood-based test.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.